Abstract

Aim:To examine the test–retest reliability of the rheumatoid arthritis (RA) core disease activity measures and derived composite indices.Methods:A total of 28 stable patients with RA had 2 complete assessments within...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB0172 Assessment of disease activity in rheumatoid arthritis by routine assessment of rheumatoid arthritis disease activity index (radai) and its relation with disease activity score 28 (das28), clinical disease activity index (cdai) and simplified disease acti
F Kaygisiz ... F Tuncay
Annals of the Rheumatic Diseases | VOL. 72
F Kaygisiz, et. al.F Kaygisiz ... F Tuncay
01 Jun 2013
AB0280 The comparative responsiveness of the patient self-report questionnaires and composite disease for assessing rheumatoid arthritis activity in routine care
S Gasparini ... S Bombardieri
Annals of the Rheumatic Diseases | VOL. 71
S Gasparini, et. al.S Gasparini ... S Bombardieri
01 Jun 2013
Performance of the Rheumatoid Arthritis Disease Activity Index in the Assessment of Disease Activity in Rheumatoid Arthritis-Findings From the REAL Study.
Leticia Rocha Pereira ... Maria Fernanda Brandão De Resende Guimarães
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases | VOL. 28
Leticia Rocha Pereira, et. al.Leticia Rocha Pereira ... Maria Fernanda Brandão De Resende Guimarães
22 Mar 2022
Rheumatology meeting: Efficacy, safety of biologics central focus
Maria G Tanzi
Pharmacy Today | VOL. 19
Maria G TanziMaria G Tanzi
01 Apr 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers